| Health / Medical Topics |
LEP-ETU
A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. LEP-ETU blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called liposomal paclitaxel, LipoTaxen, paclitaxel liposome, and PNU-93914. (NCI Dictionary)
YOU MAY ALSO LIKE
Human LEP wild-type allele is located in the vicinity of 7q31.3 and is approximately 16 kb in length. This allele, which encodes…
This gene plays a role in the modulation of appetite and the regulation of body fat storage.
A genetic syndrome caused by mutations in the PTPN11 and RAF1 genes. It is characterized by the following abnormalities: multiple lentigines, electrocardiographic…
A drug used with everolimus to treat advanced renal cell carcinoma (a type of kidney cancer) that was treated with antiangiogenesis therapy…
A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic…
Autologous, CD34-positive hematopoietic progenitor cells (HPCs) transduced with rHIV7-shI-TAR-CCR5RZ, a lentiviral vector encoding three anti-human immunodeficiency virus (HIV) RNA genes, with potential…
